Facial Injectables Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	148 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224163

Best Price Guarantee
Price	from $4,850
Length	148 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224163

Facial Injectables Market

Growth Factors of Facial Injectables Market

The facial injectables market size was valued at USD 8.93 billion in 2023, and the market is now projected to grow from USD 9.54 billion in 2024 to USD 17.24 billion by 2032, exhibiting a CAGR of 7.7% during the forecast period of 2024-2032.

According to COVID-19 impact, the overall demand for cosmetic products has dropped drastically across global markets, and therefore, the sale of cosmetics has also plunged. Top market stakeholders cut their revenues from facial injectables during the second quarter of 2020 significantly. Pandemic restrictions and lockdowns also reduced opportunities to undergo aesthetic procedures, which also affected this industry. Therefore, the cosmetic market was on less favorable ground as tested by these challenges during this period.

In the last ten years, there has been increased quests in cosmetic surgeries and minimally invasive or non-surgical procedures, including botulinum Toxin and dermal fillers. Several people go for such treatments if only to make them look young without having to go through surgeries which are invasive. Procedures that require invasive means require a lot of time in the recovery process, as well as posing various risks to the patient; therefore, non-invasive procedures are preferable. This trend is in line with the general trends observed towards more affordable and safer cosmetic procedures.

One of the trends in the market is a tendency towards the increase of demand for non-surgical or least invasive aesthetic procedures for different age, including male consumers. Surgeries such as botulinum toxin injections, dermal fillers, and other cosmetic procedures are becoming popular among men to aid in enhancing their looks to improve on the aspect of aging. This change is due to altering the perception that the grooming of males and cosmetics in general are appropriate only for females, influencing the increase in attractiveness of cosmetic procedures among men. For these reasons, the market for such treatments remains wide open.

Comprehensive Analysis of Facial Injectables Market

The facial injectables market growth is also increasing exponentially because of the segmentation of its market. This market expansion rightly provides a thorough market breakdown near to the industry considering the leading supply and demand forces. These segmentations are methodically segregated by type analysis, by application analysis and by end-user analysis. By type analysis incudes botulinum toxin, collagen, hyaluronic acid, calcium hydroxylapatite, Poly-L-lactic Acid (PLLA), polymethyl-methacrylate microspheres (PMMA), fat injection, and others. By application analysis incudes wrinkle reduction, facelift, acne scar treatment, lip enhancement, lipoatrophy treatment, and others. By end-user analysis incudes hospitals & ambulatory surgery centers, dermatology & cosmetic clinics, and others.

The North America region lead the facial injectables market share by benefitting a market size of USD 4.26 billion in 2023 due to highly aware and economically stable population.

Top players in the market have their responsibility of healthcare industrial prospectus growth of the retailing industry and the markets. These players include, Allergan Aesthetics (AbbVie Inc.), Ipsen Pharma, Merz Pharma, GALDERMA, BIOPLUS CO., LTD., Bioxis Pharmaceuticals, Sinclair (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox, Prollenium Medical Technologies these market players provide a level-playing competitive landscape.

In October 2023, Sinclair and ATGC Co., Ltd. entered a strategic collaboration, granting Sinclair a global exclusive license to develop and commercialize ATGC’s botulinum toxin product, ATGC-110, for treating glabellar lines.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.7% from 2024 to 2032

Unit Value (USD Billion)

Segmentation By Type

Botulinum Toxin
Collagen
Hyaluronic Acid
Calcium Hydroxylapatite
Poly-L-lactic Acid (PLLA)
Polymethyl-methacrylate Microspheres (PMMA)
Fat Injection
Others

By Application

Wrinkle Reduction
Facelift
Acne Scar Treatment
Lipoatrophy Treatment
Lip Enhancement
Others

By End-user

Hospitals & ASCs
Dermatology and Cosmetic Clinics
Others

By Region

North America (By Type, Application, End-user, and Country)
U.S.
Canada
Europe (By Type, Application, End-user, and Country/Sub-region)
U.K.
Germany
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
China
Japan
India
Australia
South Korea
New Zealand
Southeast Asia
Rest of Asia Pacific
Latin America (By Type, Application, End-user, and Country/Sub-region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
GCC
South Africa
Rest of the Middle East & Africa

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Overview of Facial Injection Procedures by Type, By Key Countries, 2023; 4.2. Pricing Analysis; 4.3. Key Industry Developments, By Key Players; 4.4. New Product Launches, By Key Players; 4.5. Key Industry Trends; 4.6. Impact of COVID-19 on the Market
5. Global Facial Injectables Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Type; 5.1.1. Botulinum Toxin; 5.1.2. Collagen; 5.1.3. Hyaluronic Acid (HA); 5.1.4. Calcium Hydroxylapatite (CaHA); 5.1.5. Poly-L-lactic Acid (PLLA); 5.1.6. Polymethyl-methacrylate Microspheres (PMMA); 5.1.7. Fat Injection; 5.1.8. Others; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Wrinkle Reduction; 5.2.2. Facelift; 5.2.3. Acne Scar Treatment; 5.2.4. Lipoatrophy Treatment; 5.2.5. Lip Enhancement; 5.2.6. Others; 5.3. Market Analysis, Insights and Forecast – By End-user; 5.3.1. Hospitals & ASCs; 5.3.2. Dermatology and Cosmetic Clinics; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Facial Injectables Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Type; 6.1.1. Botulinum Toxin; 6.1.2. Collagen; 6.1.3. Hyaluronic Acid; 6.1.4. Calcium Hydroxylapatite; 6.1.5. Poly-L-lactic Acid (PLLA); 6.1.6. Polymethyl-methacrylate Microspheres (PMMA); 6.1.7. Fat Injection; 6.1.8. Others; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Wrinkle Reduction; 6.2.2. Facelift; 6.2.3. Acne Scar Treatment; 6.2.4. Lipoatrophy Treatment; 6.2.5. Lip Enhancement; 6.2.6. Others; 6.3. Market Analysis, Insights and Forecast – By End-user; 6.3.1. Hospitals & ASCs; 6.3.2. Dermatology and Cosmetic Clinics; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.2. Canada
7. Europe Facial Injectables Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Type; 7.1.1. Botulinum Toxin; 7.1.2. Collagen; 7.1.3. Hyaluronic Acid (HA); 7.1.4. Calcium Hydroxylapatite (CaHA); 7.1.5. Poly-L-lactic Acid (PLLA); 7.1.6. Polymethyl-methacrylate Microspheres (PMMA); 7.1.7. Fat Injection; 7.1.8. Others; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Wrinkle Reduction; 7.2.2. Facelift; 7.2.3. Acne Scar Treatment; 7.2.4. Lipoatrophy Treatment; 7.2.5. Lip Enhancement; 7.2.6. Others; 7.3. Market Analysis, Insights and Forecast – By End-user; 7.3.1. Hospitals & ASCs; 7.3.2. Dermatology and Cosmetic Clinics; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.4.1. U.K.; 7.4.2. Germany; 7.4.3. France; 7.4.4. Italy; 7.4.5. Spain; 7.4.6. Scandinavia; 7.4.7. Rest of Europe
8. Asia Pacific Facial Injectables Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Type; 8.1.1. Botulinum Toxin; 8.1.2. Collagen; 8.1.3. Hyaluronic Acid (HA); 8.1.4. Calcium Hydroxylapatite (CaHA); 8.1.5. Poly-L-lactic Acid (PLLA); 8.1.6. Polymethyl-methacrylate Microspheres (PMMA); 8.1.7. Fat Injection; 8.1.8. Others; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Wrinkle Reduction; 8.2.2. Facelift; 8.2.3. Acne Scar Treatment; 8.2.4. Lipoatrophy Treatment; 8.2.5. Lip Enhancement; 8.2.6. Others; 8.3. Market Analysis, Insights and Forecast – By End-user; 8.3.1. Hospitals & ASCs; 8.3.2. Dermatology and Cosmetic Clinics; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 8.4.1. China; 8.4.2. Japan; 8.4.3. India; 8.4.4. Australia; 8.4.5. South Korea; 8.4.6. New Zealand; 8.4.7. Southeast Asia; 8.4.8. Rest of Asia Pacific
9. Latin America Facial Injectables Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Type; 9.1.1. Botulinum Toxin; 9.1.2. Collagen; 9.1.3. Hyaluronic Acid (HA); 9.1.4. Calcium Hydroxylapatite (CaHA); 9.1.5. Poly-L-lactic Acid (PLLA); 9.1.6. Polymethyl-methacrylate Microspheres (PMMA); 9.1.7. Fat Injection; 9.1.8. Others; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Wrinkle Reduction; 9.2.2. Facelift; 9.2.3. Acne Scar Treatment; 9.2.4. Lipoatrophy Treatment; 9.2.5. Lip Enhancement; 9.2.6. Others; 9.3. Market Analysis, Insights and Forecast – By End-user; 9.3.1. Hospitals & ASCs; 9.3.2. Dermatology and Cosmetic Clinics; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 9.4.1. Brazil; 9.4.2. Mexico; 9.4.3. Rest of Latin America
10. Middle East & Africa Facial Injectables Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Type; 10.1.1. Botulinum Toxin; 10.1.2. Collagen; 10.1.3. Hyaluronic Acid (HA); 10.1.4. Calcium Hydroxylapatite (CaHA); 10.1.5. Poly-L-lactic Acid (PLLA); 10.1.6. Polymethyl-methacrylate Microspheres (PMMA); 10.1.7. Fat Injection; 10.1.8. Others; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Wrinkle Reduction; 10.2.2. Facelift; 10.2.3. Acne Scar Treatment; 10.2.4. Lipoatrophy Treatment; 10.2.5. Lip Enhancement; 10.2.6. Others; 10.3. Market Analysis, Insights and Forecast – By End-user; 10.3.1. Hospitals & ASCs; 10.3.2. Dermatology and Cosmetic Clinics; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 10.4.1. GCC; 10.4.2. South Africa; 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Profiles of Players Operating in the Market; 11.2.1. Allergan Aesthetics (AbbVie Inc.); 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Ipsen Pharma; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Merz Pharma; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. GALDERMA; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. BIOPLUS CO., LTD.; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Bioxis Pharmaceuticals; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Sinclair (Huadong Medicine Co., Ltd.); 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. Revance Therapeutics, Inc.; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. Medytox; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 11.2.10. Prollenium Medical Technologies; 11.2.10.1. Overview; 11.2.10.2. Products & Services; 11.2.10.3. SWOT Analysis; 11.2.10.4. Recent Developments; 11.2.10.5. Strategies; 11.2.10.6. Financials (Based on Availability)